Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
2018 StandoutNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
1995
Infectious enveloped RNA virus antigenic chimeras.
1992 StandoutNobel
Humanization of an anti-p185HER2 antibody for human cancer therapy.
1992
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up
1999
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Ribosome-inactivating proteins from plants
1993
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.
1990
Pathogenesis and therapy of psoriasis
2007 StandoutNature
A genetic model for colorectal tumorigenesis
1990 Standout
Vascular targeting—a new approach to the therapy of solid tumors
1994
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
1992 StandoutNature
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Antitumour actions of interferons: implications for cancer therapy
2016
Mapping and analysis of chromatin state dynamics in nine human cell types
2011 StandoutNature
Minimizing the immunogenicity of protein therapeutics
2004
Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
2013
Murine interleukin-4 displays potent anti-tumor activity in vivo
1989
The Lipophilic Muramyl Peptide MTP-PE Is a Potent Inhibitor of HIV Replication in Macrophages
1990
Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors
1993
Lymphatic imaging in humans with near-infrared fluorescence
2009
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Hereditary Gastrointestinal Polyposis and Nonpolyposis Syndromes
1994
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review
1993
T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products
1994
Clinical Use of a Monoclonal Antibody to Bombesin‐like Peptide in Patients with Lung Cancera,b
1988
Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer
1994 StandoutNature
Mismatch Repair Deficiency in Phenotypically Normal Human Cells
1995 StandoutScienceNobel
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
1998
Cross-Priming of Cytotoxic T Cells Promoted by Apoptosis-Inducing Tumor Cell Reactive Antibodies?
2002
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Adoptive-cell-transfer therapy for the treatment of patients with cancer
2003
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
1991 StandoutScience
Signaling Recognition Events with Fluorescent Sensors and Switches
1997 Standout
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Phenotypic Analysis of Antigen-Specific T Lymphocytes
1996 StandoutScience
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
1986
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
1997 StandoutScience
Natural Killer Cells: Characteristics and Regulation of Activity
1979
Activation and differentiation requirements of primary T cells in vitro.
1993 StandoutNobel
Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line
1993
Polymyxin B causes coordinate inhibition of phorbol ester-induced C-kinase activity and proliferation of B lymphocytes
1985
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
1987 Standout
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
1997 StandoutScience
Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen
1983
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
The Role of Maintenance Therapy in Disseminated Testicular Cancer
1981
Monoclonal antibodies labeled with polymeric paramagnetic ion chelates
1986
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
1989 StandoutScience
Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.
1990
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
1982 Standout
Studies and Perspectives of Protein Kinase C
1986 StandoutScience
The pathogenesis of cancer metastasis
1980 StandoutNature
Natural Cell-Mediated Immunity
1978
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Growth Factors and Cancer
1991 StandoutScience
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity
1975
In vitro induction of T-lymphocyte-mediated cytotoxicity by infectious murine type C oncornaviruses.
1979
Cytokine Signaling Through Nonreceptor Protein Tyrosine Kinases
1995 StandoutScience
Etoposide (VP-16–213)
1985
Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies
1985
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
1997
Molecular Dynamics of Ion−Chelate Complexes Attached to Dendrimers
1996 StandoutNobel
Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs.
1995 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Immunotoxins
1986
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)
1983
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
1994 StandoutScience
Metal chelates as probes of biological systems
1984
Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon
1989
IL-2: The First Effective Immunotherapy for Human Cancer
2014
Biological therapy of cancer
1986
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Ifosfamide in refractory male germ cell tumors.
1986
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Redesigning Nature's Poisons to Create Anti-Tumor Reagents
1987 Science
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Interleukin-2: Inception, Impact, and Implications
1988 StandoutScience
Works of Robert K. Oldham being referenced
Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial
1991
Inpatient continuous-infusion interleukin-2 in 788 patients with cancer the national biotherapy study group experience
1993
Recombinant Leukocyte A Interferon in Advanced Breast Cancer
1983
Problems Associated With Study of Cell-Mediated Immunity to Human Tumors by Microcytotoxicity Assays
1975
Natural cytotoxic reactivity of rat lymphocytes against gross virus-induced tumor cell lines as measured by [125I]iododeoxyuridine and tritiated proline microcytotoxicity assays.
1977
Monoclonal Antibodies in the Lymphatics: Selective Delivery to Lymph Node Metastases of a Solid Tumor
1983 Science
Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer
1982
Natural killer cells: Artifact to reality:
1983
Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies.Clinical description
1977
Cell‐mediated immune responsiveness of patients with acute lymphocytic leukemia in remission
1976
Cellular Microcytotoxicity in Human Tumor Systems: Analysis of Results2
1975
Evaluation of Cell-Mediated Cytotoxic Reactivity Against Tumor Associated Antigens with 125I-Iododeoxyuridine Labeled Target Cells
1973
Small-Cell Lung Cancer
1979
Recombinant alpha interferon in retreatment of two patients with pulmonary lymphoma
1984
Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.
1984
Guinea pig line 10 hepatocarcinoma model: characterization of monoclonal antibody and in vivo effect of unconjugated antibody and antibody conjugated to diphtheria toxin A chain.
1983
VP-16–213 salvage therapy for refractory germinal neoplasms
1980
Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a Interferon
1984
Standardization of the Chromium-51 Release, Cell-Mediated Cytotoxicity Assay: Cryopreservation of Mouse Effector and Target Cells2
1977
Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group
1984
Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
1987
A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and Counter-current Centrifugation Elutriation (CCE)
1983
Patient-Funded Cancer Research
1987
Human natural cell-mediated cytotoxicity
1981
Endodermal sinus tumor of the mediastinum
1982
Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia
1985
Specificity of Natural Cytotoxic Reactivity of Normal Human Lymphocytes Against a Myeloid Leukemia Cell Line
1977
Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies.II. Chromosomal and immunologic abnormalities
1977
Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
1985